XML 16 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover Page - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Mar. 21, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Document Transition Report false    
Entity File Number 000-30111    
Entity Registrant Name Lexicon Pharmaceuticals, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 76-0474169    
Entity Address, Address Line One 2445 Technology Forest Blvd., 11th Floor    
Entity Address, City or Town The Woodlands,    
Entity Address, State or Province TX    
Entity Address, Postal Zip Code 77381    
City Area Code (281)    
Local Phone Number 863-3000    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol LXRX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 273.7
Entity Common Stock, Shares Outstanding   246,236,753  
Documents Incorporated by Reference
Certain sections of the registrant’s definitive proxy statement relating to the registrant’s 2024 annual meeting of stockholders, which proxy statement will be filed under the Securities Exchange Act of 1934 within 120 days of the end of the registrant’s fiscal year ended December 31, 2023, are incorporated by reference into Part III of this annual report on Form 10-K.
    
Entity Central Index Key 0001062822    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false    
Current Fiscal Year End Date --12-31